An immunoassay for the measurement of sirolimus
- 1 January 2000
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 22, B49-B61
- https://doi.org/10.1016/s0149-2918(00)89022-0
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Therapeutic drug monitoring of immunosuppressant drugsBritish Journal of Clinical Pharmacology, 1999
- SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATIONTransplantation, 1999
- Determination of Rapamycin in Whole Blood by HPLCTherapeutic Drug Monitoring, 1997
- Consensus Guidelines for Therapeutic Drug Monitoring of Rapamycin: Report of the Consensus PanelTherapeutic Drug Monitoring, 1995
- Rapamune (Sirolimus, Rapamycin): An Overview and Mechanism of ActionTherapeutic Drug Monitoring, 1995
- Sample clean-up and high-performance liquid chromatographic techniques for measurement of whole blood rapamycin concentrationsJournal of Chromatography B: Biomedical Sciences and Applications, 1994
- Blood Distribution Of RapamycinTransplantation, 1993
- Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin.Proceedings of the National Academy of Sciences, 1992
- Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinaseNature, 1992
- Measurement of Rapamycin in Whole Blood Using Reverse-Phase High-Performance Liquid ChromatographyTherapeutic Drug Monitoring, 1992